Back to Search
PERRY DURANT, DMD
DMD
General Practice Dentistry
NPI: 1760499289Individual
Specialties, Licenses & Credentials
General Practice DentistryPrimary
Dentist — General Practice
Code: 1223G0001X
2022(SC)
Research & Publications (20)
Effects of decreased calmodulin protein on the survival mechanisms of alveolar macrophages during Pneumocystis pneumonia.
PMID 19487471·Infect Immun·2009
7-preclinical
Pneumocystis mediates overexpression of antizyme inhibitor resulting in increased polyamine levels and apoptosis in alveolar macrophages.
PMID 19158080·J Biol Chem·2009
7-preclinical
Effects of prior oral contraceptive use and soy isoflavonoids on estrogen-metabolizing cytochrome P450 enzymes.
PMID 18955142·J Steroid Biochem Mol Biol·2008
7-preclinical
Decreased inflammatory response in Toll-like receptor 2 knockout mice is associated with exacerbated Pneumocystis pneumonia.
PMID 18400546·Microbes Infect·2008
7-preclinical
Polyamine-mediated apoptosis of alveolar macrophages during Pneumocystis pneumonia.
PMID 17314093·J Biol Chem·2007
7-preclinical
Caspase-9 as a target for Pneumocystis pneumonia therapy.
PMID 17169033·J Eukaryot Microbiol·2006
7-preclinical
Expression and activation of complement protein and alveolar damage during Pneumocystis pneumonia.
PMID 17169032·J Eukaryot Microbiol·2006
7-preclinical
Inflammatory cells are sources of polyamines that induce alveolar macrophage to undergo apoptosis during Pneumocystis pneumonia.
PMID 17169031·J Eukaryot Microbiol·2006
7-preclinical
Toll-like receptor 2 knockout reduces lung inflammation during Pneumocystis pneumonia but has no effect on phagocytosis of Pneumocystis organisms by alveolar macrophages.
PMID 17169030·J Eukaryot Microbiol·2006
7-preclinical
Survival pathway signal transduction is reduced in alveolar macrophages during Pneumocystis pneumonia.
PMID 17169029·J Eukaryot Microbiol·2006
7-preclinical
Transforming growth factor-beta activation and signaling in the alveolar environment during Pneumocystis pneumonia.
PMID 17169028·J Eukaryot Microbiol·2006
7-preclinical
GM-CSF expression in the lung during Pneumocystis pneumonia.
PMID 17169027·J Eukaryot Microbiol·2006
7-preclinical
Syndecan-1 expression in the lung during Pneumocystis infection.
PMID 17169026·J Eukaryot Microbiol·2006
7-preclinical
Alterations in surfactant protein A form and clearance during Pneumocystis pneumonia.
PMID 17169024·J Eukaryot Microbiol·2006
7-preclinical
Suppression of alveolar macrophage apoptosis prolongs survival of rats and mice with pneumocystis pneumonia.
PMID 16709801·J Immunol·2006
7-preclinical
Toll-like receptor 2 mediates alveolar macrophage response to Pneumocystis murina.
PMID 16495560·Infect Immun·2006
7-preclinical
Structural effects of hypermodified nucleosides in the Escherichia coli and human tRNALys anticodon loop: the effect of nucleosides s2U, mcm5U, mcm5s2U, mnm5s2U, t6A, and ms2t6A.
PMID 15924427·Biochemistry·2005
8-other
Effect of bronchoalveolar lavage fluid from Pneumocystis carinii-infected hosts on phagocytic activity of alveolar macrophages.
PMID 15039336·Infect Immun·2004
7-preclinical
Transcriptional changes in alveolar macrophages during Pneumocystis pneumonia.
PMID 14736199·J Eukaryot Microbiol·2003
7-preclinical
Transtracheal inoculation of Pneumocystis carinii in immunocompetent animals.
PMID 14736198·J Eukaryot Microbiol·2003
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 154 SEA ISLAND PKWY
BEAUFORT, SC 29907 - Phone
- (843) 986-0177
Quick Facts
- NPI
- 1760499289
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile